Pricing
Get started
Sign InGet started
Email gallery/Fernakademie für Erwachsenenbildung/Einladung: Jetzt 120,- Euro Umfrage-Prämie sichern und 4 Wochen kostenlos testen
FFFernakademie für Erwachsenenbildung

Einladung: Jetzt 120,- Euro Umfrage-Prämie sichern und 4 Wochen kostenlos testen

Einladung: Jetzt 120,- Euro Umfrage-Prämie sichern und 4 Wochen kostenlos testen email from Fernakademie für Erwachsenenbildung screenshot

Make this email yours with Migma AI

Type your website. Migma AI designs one like it with your logo, colors, and images.

This email
→
Your brand
Your logo

About this email

Captured June 12, 2026·Promotional

Promotional email inviting users to participate in a survey for a 120 Euro reward and a 4-week free trial.

Logo at top left, hero image with text overlay, followed by personalized greeting, body text, clear CTA button, and contact info with signature.

Explore similar emails

  • Corporate
  • Single Column
  • Business & B2B Retail
  • Loyalty/Rewards Offer
  • Consideration
  • Newsletter Subscribers
  • Feedback And Survey And Poll

Color palette

Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.

Solutions

  • Marketers
  • Designers
  • Developers
  • Enterprise

Resources

  • Countdowns
    New
  • Email gallery
  • Pricing
  • Docs
  • Blog
  • Customer stories

Company

  • About Us
  • Brand guidelines
  • Brand kit
  • Careers
  • Support
  • FAQ

Legal

  • Privacy Policy
  • Terms & Conditions
  • Do not sell or share my personal information
  • Copyright Notice & Takedown
  • Data Processing Agreement
  • Acceptable Use

Socials

  • X / Twitter
  • Discord
  • YouTube
  • LinkedIn
MigmaAI
© 2026 MigmaAI, Inc. All rights reserved.
Backed byEWOR Logo DarkEWOR Logo Light
Built with ❤️ in Stockholm & Barcelona

More emails like this

Explore other emails with shared design, campaign, or industry tags.

Takeda Announces FY2026 First-Half Results Highlighting Launch Momentum and Pipeline Milestones email from Takeda Pharmaceutical
TPTakeda Pharmaceutical

Takeda Announces FY2026 First-Half Results Highlighting Launch Momentum and Pipeline Milestones

Create this for my brand
First and Only Ulcerative Colitis Treat-to-Target Trial Shows Treating to Disease Clearance vs. Symptomatic Remission with ENTYVIO® (vedolizumab) Prolongs Time to First Disease-Related Complication email from Takeda Pharmaceutical
TPTakeda Pharmaceutical

First and Only Ulcerative Colitis Treat-to-Target Trial Shows Treating to Disease Clearance vs. Symptomatic Remission with ENTYVIO® (vedolizumab) Prolongs Time to First Disease-Related Complication

Create this for my brand
Most cards make you choose. This one doesn't. email from The Motley Fool
The Motley Fool logoThe Motley Fool

Most cards make you choose. This one doesn't.

Create this for my brand
Svi imaju mišljenje o poslu. Nas zanima baš tvoje! email from MojPosao
MMojPosao

Svi imaju mišljenje o poslu. Nas zanima baš tvoje!

Create this for my brand
who are you? email from Omniscient Digital
Omniscient Digital logoOmniscient Digital

who are you?

Create this for my brand
Every needs your help email from Every
Every logoEvery

Every needs your help

Create this for my brand
NACRJ: Help Shape the Future of NACRJ - 2026 Community Survey email from National Association of Community and Restorative Justice (NACRJ)
NANational Association of Community and Restorative Justice (NACRJ)

NACRJ: Help Shape the Future of NACRJ - 2026 Community Survey

Create this for my brand
Meet the winners of Inman’s 2026 Best of Proptech Awards email from Real Estate Connect
REReal Estate Connect

Meet the winners of Inman’s 2026 Best of Proptech Awards

Create this for my brand